Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Clinical characteristics and outcomes of oligosecretory and non-secretory multiple myeloma
Magdalini Migkou, Irit Avivi, Maria Gavriatopoulou, Yaël C. Cohen, Despina Fotiou, Nikolaos Kanellias, Dimitrios C. Ziogas, Evangelos Eleutherakis‐Papaiakovou, Evangelos Terpos, Μαρία Ρούσσου, Efstathios Kastritis, Meletios A Dimopoulos (2020). Clinical characteristics and outcomes of oligosecretory and non-secretory multiple myeloma. , 99(6), DOI: https://doi.org/10.1007/s00277-020-03984-w.
Article40 days agoEarly Relapse After Autologous Transplant Is Associated With Very Poor Survival and Identifies an Ultra-High-Risk Group of Patients With Myeloma
Efstathios Kastritis, Μαρία Ρούσσου, Evangelos Eleutherakis‐Papaiakovou, Maria Gavriatopoulou, Magdalini Migkou, Dimitra Gika, Despina Fotiou, Nikolaos Kanellias, Dimitrios C. Ziogas, Ioannis Ntanasis‐Stathopoulos, Despoina Mparmparousi, Anastasia Gatou, Despina Katopi, Efstathios Manios, Michalis Liontos, Stavroula Giannouli, Panagiotis Tsirigotis, Evangelos Terpos, Meletios A Dimopoulos (2020). Early Relapse After Autologous Transplant Is Associated With Very Poor Survival and Identifies an Ultra-High-Risk Group of Patients With Myeloma. , 20(7), DOI: https://doi.org/10.1016/j.clml.2019.10.014.
Article40 days agoEarly Relapse After Autologous Transplant Is Associated With Very Poor Survival and Identifies an Ultra-High-Risk Group of Patients With Myeloma
Efstathios Kastritis, Μαρία Ρούσσου, Evangelos Eleutherakis‐Papaiakovou, Maria Gavriatopoulou, Magdalini Migkou, Dimitra Gika, Despina Fotiou, Nikolaos Kanellias, Dimitrios C. Ziogas, Ioannis Ntanasis‐Stathopoulos, Despoina Mparmparousi, Anastasia Gatou, Despina Katopi, Efstathios Manios, Michalis Liontos, Stavroula Giannouli, Panagiotis Tsirigotis, Evangelos Terpos, Meletios A Dimopoulos (2020). Early Relapse After Autologous Transplant Is Associated With Very Poor Survival and Identifies an Ultra-High-Risk Group of Patients With Myeloma. , 20(7), DOI: https://doi.org/10.1016/j.clml.2019.10.014.
Article40 days agoPrimary treatment of light-chain amyloidosis with bortezomib, lenalidomide, and dexamethasone
Efstathios Kastritis, Ioanna Dialoupi, Maria Gavriatopoulou, Μαρία Ρούσσου, Nikolaos Kanellias, Despina Fotiou, Ioannis Ntanasis‐Stathopoulos, Elektra Papadopoulou, Dimitrios C. Ziogas, Κimon Stamatelopoulos, Efstathios Manios, Argyrios Ntalianis, Evangelos Eleutherakis‐Papaiakovou, Asimina Papanikolaou, Magdalini Migkou, Αριστέα-Μαρία Παπανώτα, Harikleia Gakiopoulou, Erasmia Psimenou, Maria Irini Tselegkidi, Ourania Tsitsilonis, Ioannis V. Kostopoulos, Evangelos Terpos, Meletios A Dimopoulos (2019). Primary treatment of light-chain amyloidosis with bortezomib, lenalidomide, and dexamethasone. , 3(20), DOI: https://doi.org/10.1182/bloodadvances.2019000147.
Article40 days agoA new genetic variant of hereditary apolipoprotein A-I amyloidosis: a case-report followed by discussion of diagnostic challenges and therapeutic options
Myrto Moutafi, Dimitrios C. Ziogas, Spyridon Michopoulos, Tina Bagratuni, Vassiliki Vasileiou, Laura Verga, Giampaolo Merlini, Giovanni Palladini, Charis Matsouka, Meletios A Dimopoulos, Efstathios Kastritis (2019). A new genetic variant of hereditary apolipoprotein A-I amyloidosis: a case-report followed by discussion of diagnostic challenges and therapeutic options. , 20(1), DOI: https://doi.org/10.1186/s12881-019-0755-5.
Article40 days ago